カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のアポモルヒネ塩酸塩注射液市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Apomorphine Hydrochloride Injection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO17125）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO17125
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：72
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のアポモルヒネ塩酸塩注射液市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

アポモルヒネ塩酸塩注射液市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のアポモルヒネ塩酸塩注射液の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

アポモルヒネ塩酸塩注射液市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ペン型注射器、輸液ポンプ

用途別セグメントは次のように区分されます。
・パーキンソン病、勃起不全

世界のアポモルヒネ塩酸塩注射液市場の主要な市場プレーヤーは以下のとおりです。
・Supernus Pharmaceuticals、Britannia Pharmaceuticals STADA、Ever Pharma、Evolan Pharma AB (PharmSwed)

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、アポモルヒネ塩酸塩注射液製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なアポモルヒネ塩酸塩注射液メーカーの企業概要、2019年～2022年までのアポモルヒネ塩酸塩注射液の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なアポモルヒネ塩酸塩注射液メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別アポモルヒネ塩酸塩注射液の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのアポモルヒネ塩酸塩注射液の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのアポモルヒネ塩酸塩注射液市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびアポモルヒネ塩酸塩注射液の産業チェーンを掲載しています。
・第13、14、15章では、アポモルヒネ塩酸塩注射液の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- アポモルヒネ塩酸塩注射液の概要
- 種類別分析（2017年vs2021年vs2028年）：ペン型注射器、輸液ポンプ
- 用途別分析（2017年vs2021年vs2028年）：パーキンソン病、勃起不全
- 世界のアポモルヒネ塩酸塩注射液市場規模・予測
- 世界のアポモルヒネ塩酸塩注射液生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Supernus Pharmaceuticals、Britannia Pharmaceuticals STADA、Ever Pharma、Evolan Pharma AB (PharmSwed)
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ペン型注射器、輸液ポンプ
・用途別分析2017年-2028年：パーキンソン病、勃起不全
・アポモルヒネ塩酸塩注射液の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・アポモルヒネ塩酸塩注射液のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・アポモルヒネ塩酸塩注射液のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・アポモルヒネ塩酸塩注射液の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・アポモルヒネ塩酸塩注射液の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Apomorphine Hydrochloride Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Apomorphine Hydrochloride Injection market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Parkinson Disease accounting for % of the Apomorphine Hydrochloride Injection global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Pen Injectors segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Apomorphine Hydrochloride Injection include Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma, Evolan Pharma AB (PharmSwed), and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Apomorphine Hydrochloride Injection market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Pen Injectors
Infusion Pumps
Market segment by Application can be divided into
Parkinson Disease
Erectile Dysfunction
The key market players for global Apomorphine Hydrochloride Injection market are listed below:
Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
Ever Pharma
Evolan Pharma AB (PharmSwed)
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Apomorphine Hydrochloride Injection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Apomorphine Hydrochloride Injection, with price, sales, revenue and global market share of Apomorphine Hydrochloride Injection from 2019 to 2022.
Chapter 3, the Apomorphine Hydrochloride Injection competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Apomorphine Hydrochloride Injection breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Apomorphine Hydrochloride Injection market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Apomorphine Hydrochloride Injection.
Chapter 13, 14, and 15, to describe Apomorphine Hydrochloride Injection sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Apomorphine Hydrochloride Injection Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Apomorphine Hydrochloride Injection Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Pen Injectors
1.2.3 Infusion Pumps
1.3 Market Analysis by Application
1.3.1 Overview: Global Apomorphine Hydrochloride Injection Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Parkinson Disease
1.3.3 Erectile Dysfunction
1.4 Global Apomorphine Hydrochloride Injection Market Size & Forecast
1.4.1 Global Apomorphine Hydrochloride Injection Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Apomorphine Hydrochloride Injection Sales in Volume (2017-2028)
1.4.3 Global Apomorphine Hydrochloride Injection Price (2017-2028)
1.5 Global Apomorphine Hydrochloride Injection Production Capacity Analysis
1.5.1 Global Apomorphine Hydrochloride Injection Total Production Capacity (2017-2028)
1.5.2 Global Apomorphine Hydrochloride Injection Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Apomorphine Hydrochloride Injection Market Drivers
1.6.2 Apomorphine Hydrochloride Injection Market Restraints
1.6.3 Apomorphine Hydrochloride Injection Trends Analysis
2 Manufacturers Profiles
2.1 Supernus Pharmaceuticals
2.1.1 Supernus Pharmaceuticals Details
2.1.2 Supernus Pharmaceuticals Major Business
2.1.3 Supernus Pharmaceuticals Apomorphine Hydrochloride Injection Product and Services
2.1.4 Supernus Pharmaceuticals Apomorphine Hydrochloride Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Britannia Pharmaceuticals STADA
2.2.1 Britannia Pharmaceuticals STADA Details
2.2.2 Britannia Pharmaceuticals STADA Major Business
2.2.3 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Injection Product and Services
2.2.4 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Ever Pharma
2.3.1 Ever Pharma Details
2.3.2 Ever Pharma Major Business
2.3.3 Ever Pharma Apomorphine Hydrochloride Injection Product and Services
2.3.4 Ever Pharma Apomorphine Hydrochloride Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Evolan Pharma AB (PharmSwed)
2.4.1 Evolan Pharma AB (PharmSwed) Details
2.4.2 Evolan Pharma AB (PharmSwed) Major Business
2.4.3 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Injection Product and Services
2.4.4 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Apomorphine Hydrochloride Injection Breakdown Data by Manufacturer
3.1 Global Apomorphine Hydrochloride Injection Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Apomorphine Hydrochloride Injection Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Apomorphine Hydrochloride Injection
3.4 Market Concentration Rate
3.4.1 Top 3 Apomorphine Hydrochloride Injection Manufacturer Market Share in 2021
3.4.2 Top 6 Apomorphine Hydrochloride Injection Manufacturer Market Share in 2021
3.5 Global Apomorphine Hydrochloride Injection Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Apomorphine Hydrochloride Injection Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Apomorphine Hydrochloride Injection Market Size by Region
4.1.1 Global Apomorphine Hydrochloride Injection Sales in Volume by Region (2017-2028)
4.1.2 Global Apomorphine Hydrochloride Injection Revenue by Region (2017-2028)
4.2 North America Apomorphine Hydrochloride Injection Revenue (2017-2028)
4.3 Europe Apomorphine Hydrochloride Injection Revenue (2017-2028)
4.4 Asia-Pacific Apomorphine Hydrochloride Injection Revenue (2017-2028)
4.5 South America Apomorphine Hydrochloride Injection Revenue (2017-2028)
4.6 Middle East and Africa Apomorphine Hydrochloride Injection Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Apomorphine Hydrochloride Injection Sales in Volume by Type (2017-2028)
5.2 Global Apomorphine Hydrochloride Injection Revenue by Type (2017-2028)
5.3 Global Apomorphine Hydrochloride Injection Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Apomorphine Hydrochloride Injection Sales in Volume by Application (2017-2028)
6.2 Global Apomorphine Hydrochloride Injection Revenue by Application (2017-2028)
6.3 Global Apomorphine Hydrochloride Injection Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Apomorphine Hydrochloride Injection Sales by Type (2017-2028)
7.2 North America Apomorphine Hydrochloride Injection Sales by Application (2017-2028)
7.3 North America Apomorphine Hydrochloride Injection Market Size by Country
7.3.1 North America Apomorphine Hydrochloride Injection Sales in Volume by Country (2017-2028)
7.3.2 North America Apomorphine Hydrochloride Injection Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Apomorphine Hydrochloride Injection Sales by Type (2017-2028)
8.2 Europe Apomorphine Hydrochloride Injection Sales by Application (2017-2028)
8.3 Europe Apomorphine Hydrochloride Injection Market Size by Country
8.3.1 Europe Apomorphine Hydrochloride Injection Sales in Volume by Country (2017-2028)
8.3.2 Europe Apomorphine Hydrochloride Injection Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Apomorphine Hydrochloride Injection Sales by Type (2017-2028)
9.2 Asia-Pacific Apomorphine Hydrochloride Injection Sales by Application (2017-2028)
9.3 Asia-Pacific Apomorphine Hydrochloride Injection Market Size by Region
9.3.1 Asia-Pacific Apomorphine Hydrochloride Injection Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Apomorphine Hydrochloride Injection Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Apomorphine Hydrochloride Injection Sales by Type (2017-2028)
10.2 South America Apomorphine Hydrochloride Injection Sales by Application (2017-2028)
10.3 South America Apomorphine Hydrochloride Injection Market Size by Country
10.3.1 South America Apomorphine Hydrochloride Injection Sales in Volume by Country (2017-2028)
10.3.2 South America Apomorphine Hydrochloride Injection Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Apomorphine Hydrochloride Injection Sales by Type (2017-2028)
11.2 Middle East & Africa Apomorphine Hydrochloride Injection Sales by Application (2017-2028)
11.3 Middle East & Africa Apomorphine Hydrochloride Injection Market Size by Country
11.3.1 Middle East & Africa Apomorphine Hydrochloride Injection Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Apomorphine Hydrochloride Injection Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Apomorphine Hydrochloride Injection and Key Manufacturers
12.2 Manufacturing Costs Percentage of Apomorphine Hydrochloride Injection
12.3 Apomorphine Hydrochloride Injection Production Process
12.4 Apomorphine Hydrochloride Injection Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Apomorphine Hydrochloride Injection Typical Distributors
13.3 Apomorphine Hydrochloride Injection Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Apomorphine Hydrochloride Injection Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Apomorphine Hydrochloride Injection Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Supernus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Supernus Pharmaceuticals Major Business
Table 5. Supernus Pharmaceuticals Apomorphine Hydrochloride Injection Product and Services
Table 6. Supernus Pharmaceuticals Apomorphine Hydrochloride Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Britannia Pharmaceuticals STADA Basic Information, Manufacturing Base and Competitors
Table 8. Britannia Pharmaceuticals STADA Major Business
Table 9. Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Injection Product and Services
Table 10. Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Ever Pharma Basic Information, Manufacturing Base and Competitors
Table 12. Ever Pharma Major Business
Table 13. Ever Pharma Apomorphine Hydrochloride Injection Product and Services
Table 14. Ever Pharma Apomorphine Hydrochloride Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Evolan Pharma AB (PharmSwed) Basic Information, Manufacturing Base and Competitors
Table 16. Evolan Pharma AB (PharmSwed) Major Business
Table 17. Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Injection Product and Services
Table 18. Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Global Apomorphine Hydrochloride Injection Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 20. Global Apomorphine Hydrochloride Injection Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 21. Market Position of Manufacturers in Apomorphine Hydrochloride Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 22. Global Apomorphine Hydrochloride Injection Production Capacity by Company, (K Units): 2020 VS 2021
Table 23. Head Office and Apomorphine Hydrochloride Injection Production Site of Key Manufacturer
Table 24. Apomorphine Hydrochloride Injection New Entrant and Capacity Expansion Plans
Table 25. Apomorphine Hydrochloride Injection Mergers & Acquisitions in the Past Five Years
Table 26. Global Apomorphine Hydrochloride Injection Sales by Region (2017-2022) & (K Units)
Table 27. Global Apomorphine Hydrochloride Injection Sales by Region (2023-2028) & (K Units)
Table 28. Global Apomorphine Hydrochloride Injection Revenue by Region (2017-2022) & (USD Million)
Table 29. Global Apomorphine Hydrochloride Injection Revenue by Region (2023-2028) & (USD Million)
Table 30. Global Apomorphine Hydrochloride Injection Sales by Type (2017-2022) & (K Units)
Table 31. Global Apomorphine Hydrochloride Injection Sales by Type (2023-2028) & (K Units)
Table 32. Global Apomorphine Hydrochloride Injection Revenue by Type (2017-2022) & (USD Million)
Table 33. Global Apomorphine Hydrochloride Injection Revenue by Type (2023-2028) & (USD Million)
Table 34. Global Apomorphine Hydrochloride Injection Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Apomorphine Hydrochloride Injection Price by Type (2023-2028) & (US$/Unit)
Table 36. Global Apomorphine Hydrochloride Injection Sales by Application (2017-2022) & (K Units)
Table 37. Global Apomorphine Hydrochloride Injection Sales by Application (2023-2028) & (K Units)
Table 38. Global Apomorphine Hydrochloride Injection Revenue by Application (2017-2022) & (USD Million)
Table 39. Global Apomorphine Hydrochloride Injection Revenue by Application (2023-2028) & (USD Million)
Table 40. Global Apomorphine Hydrochloride Injection Price by Application (2017-2022) & (US$/Unit)
Table 41. Global Apomorphine Hydrochloride Injection Price by Application (2023-2028) & (US$/Unit)
Table 42. North America Apomorphine Hydrochloride Injection Sales by Country (2017-2022) & (K Units)
Table 43. North America Apomorphine Hydrochloride Injection Sales by Country (2023-2028) & (K Units)
Table 44. North America Apomorphine Hydrochloride Injection Revenue by Country (2017-2022) & (USD Million)
Table 45. North America Apomorphine Hydrochloride Injection Revenue by Country (2023-2028) & (USD Million)
Table 46. North America Apomorphine Hydrochloride Injection Sales by Type (2017-2022) & (K Units)
Table 47. North America Apomorphine Hydrochloride Injection Sales by Type (2023-2028) & (K Units)
Table 48. North America Apomorphine Hydrochloride Injection Sales by Application (2017-2022) & (K Units)
Table 49. North America Apomorphine Hydrochloride Injection Sales by Application (2023-2028) & (K Units)
Table 50. Europe Apomorphine Hydrochloride Injection Sales by Country (2017-2022) & (K Units)
Table 51. Europe Apomorphine Hydrochloride Injection Sales by Country (2023-2028) & (K Units)
Table 52. Europe Apomorphine Hydrochloride Injection Revenue by Country (2017-2022) & (USD Million)
Table 53. Europe Apomorphine Hydrochloride Injection Revenue by Country (2023-2028) & (USD Million)
Table 54. Europe Apomorphine Hydrochloride Injection Sales by Type (2017-2022) & (K Units)
Table 55. Europe Apomorphine Hydrochloride Injection Sales by Type (2023-2028) & (K Units)
Table 56. Europe Apomorphine Hydrochloride Injection Sales by Application (2017-2022) & (K Units)
Table 57. Europe Apomorphine Hydrochloride Injection Sales by Application (2023-2028) & (K Units)
Table 58. Asia-Pacific Apomorphine Hydrochloride Injection Sales by Region (2017-2022) & (K Units)
Table 59. Asia-Pacific Apomorphine Hydrochloride Injection Sales by Region (2023-2028) & (K Units)
Table 60. Asia-Pacific Apomorphine Hydrochloride Injection Revenue by Region (2017-2022) & (USD Million)
Table 61. Asia-Pacific Apomorphine Hydrochloride Injection Revenue by Region (2023-2028) & (USD Million)
Table 62. Asia-Pacific Apomorphine Hydrochloride Injection Sales by Type (2017-2022) & (K Units)
Table 63. Asia-Pacific Apomorphine Hydrochloride Injection Sales by Type (2023-2028) & (K Units)
Table 64. Asia-Pacific Apomorphine Hydrochloride Injection Sales by Application (2017-2022) & (K Units)
Table 65. Asia-Pacific Apomorphine Hydrochloride Injection Sales by Application (2023-2028) & (K Units)
Table 66. South America Apomorphine Hydrochloride Injection Sales by Country (2017-2022) & (K Units)
Table 67. South America Apomorphine Hydrochloride Injection Sales by Country (2023-2028) & (K Units)
Table 68. South America Apomorphine Hydrochloride Injection Revenue by Country (2017-2022) & (USD Million)
Table 69. South America Apomorphine Hydrochloride Injection Revenue by Country (2023-2028) & (USD Million)
Table 70. South America Apomorphine Hydrochloride Injection Sales by Type (2017-2022) & (K Units)
Table 71. South America Apomorphine Hydrochloride Injection Sales by Type (2023-2028) & (K Units)
Table 72. South America Apomorphine Hydrochloride Injection Sales by Application (2017-2022) & (K Units)
Table 73. South America Apomorphine Hydrochloride Injection Sales by Application (2023-2028) & (K Units)
Table 74. Middle East & Africa Apomorphine Hydrochloride Injection Sales by Region (2017-2022) & (K Units)
Table 75. Middle East & Africa Apomorphine Hydrochloride Injection Sales by Region (2023-2028) & (K Units)
Table 76. Middle East & Africa Apomorphine Hydrochloride Injection Revenue by Region (2017-2022) & (USD Million)
Table 77. Middle East & Africa Apomorphine Hydrochloride Injection Revenue by Region (2023-2028) & (USD Million)
Table 78. Middle East & Africa Apomorphine Hydrochloride Injection Sales by Type (2017-2022) & (K Units)
Table 79. Middle East & Africa Apomorphine Hydrochloride Injection Sales by Type (2023-2028) & (K Units)
Table 80. Middle East & Africa Apomorphine Hydrochloride Injection Sales by Application (2017-2022) & (K Units)
Table 81. Middle East & Africa Apomorphine Hydrochloride Injection Sales by Application (2023-2028) & (K Units)
Table 82. Apomorphine Hydrochloride Injection Raw Material
Table 83. Key Manufacturers of Apomorphine Hydrochloride Injection Raw Materials
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Apomorphine Hydrochloride Injection Typical Distributors
Table 87. Apomorphine Hydrochloride Injection Typical Customers
List of Figures
Figure 1. Apomorphine Hydrochloride Injection Picture
Figure 2. Global Apomorphine Hydrochloride Injection Revenue Market Share by Type in 2021
Figure 3. Pen Injectors
Figure 4. Infusion Pumps
Figure 5. Global Apomorphine Hydrochloride Injection Revenue Market Share by Application in 2021
Figure 6. Parkinson Disease
Figure 7. Erectile Dysfunction
Figure 8. Global Apomorphine Hydrochloride Injection Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Apomorphine Hydrochloride Injection Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Apomorphine Hydrochloride Injection Sales (2017-2028) & (K Units)
Figure 11. Global Apomorphine Hydrochloride Injection Price (2017-2028) & (US$/Unit)
Figure 12. Global Apomorphine Hydrochloride Injection Production Capacity (2017-2028) & (K Units)
Figure 13. Global Apomorphine Hydrochloride Injection Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Apomorphine Hydrochloride Injection Market Drivers
Figure 15. Apomorphine Hydrochloride Injection Market Restraints
Figure 16. Apomorphine Hydrochloride Injection Market Trends
Figure 17. Global Apomorphine Hydrochloride Injection Sales Market Share by Manufacturer in 2021
Figure 18. Global Apomorphine Hydrochloride Injection Revenue Market Share by Manufacturer in 2021
Figure 19. Apomorphine Hydrochloride Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Apomorphine Hydrochloride Injection Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Apomorphine Hydrochloride Injection Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Apomorphine Hydrochloride Injection Sales Market Share by Region (2017-2028)
Figure 23. Global Apomorphine Hydrochloride Injection Revenue Market Share by Region (2017-2028)
Figure 24. North America Apomorphine Hydrochloride Injection Revenue (2017-2028) & (USD Million)
Figure 25. Europe Apomorphine Hydrochloride Injection Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Apomorphine Hydrochloride Injection Revenue (2017-2028) & (USD Million)
Figure 27. South America Apomorphine Hydrochloride Injection Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Apomorphine Hydrochloride Injection Revenue (2017-2028) & (USD Million)
Figure 29. Global Apomorphine Hydrochloride Injection Sales Market Share by Type (2017-2028)
Figure 30. Global Apomorphine Hydrochloride Injection Revenue Market Share by Type (2017-2028)
Figure 31. Global Apomorphine Hydrochloride Injection Price by Type (2017-2028) & (US$/Unit)
Figure 32. Global Apomorphine Hydrochloride Injection Sales Market Share by Application (2017-2028)
Figure 33. Global Apomorphine Hydrochloride Injection Revenue Market Share by Application (2017-2028)
Figure 34. Global Apomorphine Hydrochloride Injection Price by Application (2017-2028) & (US$/Unit)
Figure 35. North America Apomorphine Hydrochloride Injection Sales Market Share by Type (2017-2028)
Figure 36. North America Apomorphine Hydrochloride Injection Sales Market Share by Application (2017-2028)
Figure 37. North America Apomorphine Hydrochloride Injection Sales Market Share by Country (2017-2028)
Figure 38. North America Apomorphine Hydrochloride Injection Revenue Market Share by Country (2017-2028)
Figure 39. United States Apomorphine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Apomorphine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Apomorphine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Apomorphine Hydrochloride Injection Sales Market Share by Type (2017-2028)
Figure 43. Europe Apomorphine Hydrochloride Injection Sales Market Share by Application (2017-2028)
Figure 44. Europe Apomorphine Hydrochloride Injection Sales Market Share by Country (2017-2028)
Figure 45. Europe Apomorphine Hydrochloride Injection Revenue Market Share by Country (2017-2028)
Figure 46. Germany Apomorphine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Apomorphine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Apomorphine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Apomorphine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Apomorphine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Apomorphine Hydrochloride Injection Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Apomorphine Hydrochloride Injection Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Apomorphine Hydrochloride Injection Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Apomorphine Hydrochloride Injection Revenue Market Share by Region (2017-2028)
Figure 55. China Apomorphine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Apomorphine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Apomorphine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Apomorphine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Apomorphine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Apomorphine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Apomorphine Hydrochloride Injection Sales Market Share by Type (2017-2028)
Figure 62. South America Apomorphine Hydrochloride Injection Sales Market Share by Application (2017-2028)
Figure 63. South America Apomorphine Hydrochloride Injection Sales Market Share by Country (2017-2028)
Figure 64. South America Apomorphine Hydrochloride Injection Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Apomorphine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Apomorphine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Apomorphine Hydrochloride Injection Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Apomorphine Hydrochloride Injection Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Apomorphine Hydrochloride Injection Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Apomorphine Hydrochloride Injection Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Apomorphine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Apomorphine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Apomorphine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Apomorphine Hydrochloride Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Apomorphine Hydrochloride Injection in 2021
Figure 76. Manufacturing Process Analysis of Apomorphine Hydrochloride Injection
Figure 77. Apomorphine Hydrochloride Injection Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のアポモルヒネ送達装置市場2022年：市場規模予測（～2028年）
  • 世界のレボフロキサシン塩酸塩注射液市場2022年：市場規模予測（～2028年）
  • クリンダマイシン塩酸塩注射液の世界市場2023年：0.15g、0.3g、0.45g、0.6g
  • 注射用塩酸クリンダマイシンの世界市場2023年：筋肉注射、点滴
  • 塩酸テトラカイン注射液のグローバル市場展望 2023年-2029年：25mg、50mg、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO17125 )"世界のアポモルヒネ塩酸塩注射液市場2022年：市場規模予測（～2028年）" (英文：Global Apomorphine Hydrochloride Injection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。